Steroids for patients in septic shock: The results of the CORTICUS trial

Canadian Journal of Emergency Medicine

Volumn 13, Issue 4, 2011, Pages 273-276

  Toma, Alina ^a   Stone, Angela ^a   Green, Robert S ^b   Gray, Sara ^c  

^a UNIVERSITY OF TORONTO   (Canada)

^b DALHOUSIE UNIVERSITY   (Canada)

^c ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

Sepsis; Shock; Steroids

Indexed keywords

CORTICOTROPIN; HYDROCORTISONE; PLACEBO;

ADULT; ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORTICOTROPIN TEST; DOUBLE BLIND PROCEDURE; DRUG FATALITY; FOLLOW UP; HOSPITAL ADMISSION; HUMAN; HYPERGLYCEMIA; HYPERNATREMIA; HYPOTENSION; INTENSIVE CARE UNIT; LENGTH OF STAY; MAJOR CLINICAL STUDY; MORTALITY; MULTICENTER STUDY; POLYNEUROPATHY; RANDOMIZED CONTROLLED TRIAL; SEPSIS; SEPTIC SHOCK; SUPERINFECTION; SYSTOLIC BLOOD PRESSURE; TREATMENT OUTCOME;

EID: 80052423495     PISSN: 14818035     EISSN: None     Source Type: Journal    
DOI: 10.2310/8000.2011.110243     Document Type: Article

References (20)

1. Martin GS, Mannino DM, Eaton S, et al. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 2003;348:1546-54, doi:10.1056/NEJMoa022139.
2. Dombrovskiy VY, Martin AA, Sunderram J, et al. Rapid increase in hospitalization and mortality rates for severe sepsis in the United States: a trend analysis from 1993 to 2003. Crit Care Med 2007;35:1244-50, doi:10.1097/01.CCM. 0000261890.41311.E9.
3. Esper A, Martin GS. Is severe sepsis increasing in incidence AND severity? Crit Care Med 2007;35:1414, doi:10.1097/ 01.CCM.0000262946.68003.21.
4. Padkin A, Goldfrad C, Brady AR, et al. Epidemiology of severe sepsis occurring in the first 24 hrs in intensive care units in England, Wales, and Northern Ireland. Crit Care Med 2003;31:2332-8, doi:10.1097/01.CCM.0000085141. 75513.2B.
5. Vincent JL, Sakr Y, Sprung CL, et al. Sepsis in European intensive care units: results of the SOAP study. Crit Care Med 2006;34:344-53, doi:10.1097/01.CCM.0000194725.48928.3A.
6. Dombrovskiy VY, Martin AA, Sunderram J, et al. Facing the challenge: decreasing case fatality rates in severe sepsis despite increasing hospitalizations. Crit Care Med 2005;33: 2555-62, doi:10.1097/01.CCM.0000186748.64438.7B.
7. Marx JA, Hockberger RS, Walls RM. Rosen's emergency medicine, concepts and clinical practice, 7th ed. Philadelphia: Mosby Elsevier, 2010.
8. Annane D, Maxime V, Ibrahim F, et al. Diagnosis of adrenal insufficiency in severe sepsis and septic shock. Am J Respir Crit Care Med 2006;174:1319-26, doi:10.1164/rccm.200509-1369OC.
9. Sprung CL, Annane D, Keh D, et al. Hydrocortisone therapy for patients with septic shock. N Engl J Med 2008; 358:111-24, doi:10.1056/NEJMoa071366.
10. Dellinger RP, Caler JM, Masur H, et al. Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Crit Care Med 2004;32:858-73, doi:10.1097/ 01.CCM.0000117317.18092.E4.
11. Dellinger RP, Carlet JM, Masur H, et al. Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Intensive Care Med 2004;30:536-55, doi:10.1007/ s00134-004-2398-y.
12. Rivers E, Nguyen B, Havstad S, et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001;345:1368, doi:10.1056/NEJMoa010307.
13. Green RS, Djogovic D, Gray S, et al. Canadian Association of Emergency Physicians Sepsis guidelines: the optimal management of severe sepsis in Canadian emergency departments. CJEM 2008;10:443-59.
14. Dellinger RP, Levy MM, Carlet JM, et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Intensive Care Med 2008;34:17-60, doi:10.1007/s00134-007-0934-2.
15. Marik PE, Pastores SM, Annane D, et al. Recommendations for the diagnosis and management of corticosteroid insufficiency in critically ill patients: consensus statements from an international task force by the American College of Critical Care Medicine. Crit Care Med 2008;36:1937-49, doi:10. 1097/CCM.0b013e31817603ba.
16. Annane D, Bellissant E, Bollaert PE. Corticosteroids in the treatment of severe sepsis and septic shock in adults: a systematic review. JAMA 2009;301:2362-75, doi:10.1001/jama.2009.815.
17. Annane D, Sebille V, Charpentier C, et al. Effect of treatment with low doses of hydrocortisone and fludrocorti-sone on mortality in patients with septic shock. JAMA 2002; 288:862-71, doi:10.1001/jama.288.7.862.
18. Mueller PS, Montori VM, Bassler D, et al. Ethical issue in stopping randomized trials early because of apparent benefit. Ann Intern Med 2007;146:878-81.
19. Bassler D, Briel M, Montori VM, et al. Stopping randomized trials early for benefit and estimation of treatment effects: systematic review and meta-regression analysis. JAMA 2010;303:1180-7, doi:10.1001/jama.2010.310.
20. Montori VM, Devereaux PJ, Adhikari NKJ, et al. Randomized trials stopped early for benefit: a systematic review. JAMA 2005;294:2203-9, doi:10.1001/jama.294.17. 2203.